B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PSMD1

MOLECULAR TARGET

proteasome 26S subunit, non-ATPase 1

UniProt: Q99460NCBI Gene: 57072 compounds

PSMD1 (proteasome 26S subunit, non-ATPase 1) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PSMD1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Bortezomib2.4811
2Pioglitazone0.691

About PSMD1 as a Drug Target

PSMD1 (proteasome 26S subunit, non-ATPase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented PSMD1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PSMD1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.